Join us at APIC 2026 June 15-17 in Nashville!
We are proud to participate in APIC 2026, where infection prevention professionals come together to address emerging threats, share best practices, and advance patient safety.
At this year’s meeting, we will be featuring Simplexa® C. auris Direct, the first FDA-authorized assay for Candida auris detection, and highlighting how rapid, onsite PCR testing can support timely decision-making, smarter isolation strategies, and improved patient flow when managing C. auris; stop by the Diasorin Booth #1411 to learn more and see how these innovations can elevate your infection control strategies.
Join us at our Exhibitor Theater Session on June 16th for a discussion on C. auris!
Test Faster, Isolate Smarter: Improving Patient Flow While Containing C. auris
Speaker
Dr. Sarah Elliot
Sr. Principal Scientist, Diasorin Scientific Affairs
Date: Tuesday, June 16
Time: 12:45 PM CST
Location: Exhibit Hall – Exhibitor Theater
C. auris continues to present significant challenges for healthcare facilities due to its high transmissibility, environmental persistence, and frequent resistance to antifungal therapy. Rapid identification and informed isolation decisions are critical to reducing spread while maintaining operational efficiency.
Join Dr. Sarah Elliott, Sr. Principal Scientist, Diasorin Scientific Affairs, for a timely, interactive session exploring how onsite PCR testing can support infection prevention teams by helping to:
- Improve patient flow and cohorting
- Reduce transmission risk
- Lower institutional and operational costs
